DPP4 and metabolic dysfunction-associated steatotic liver disease: Thus, the authors claim that enhanced DPP4 expression in NAFLD liver may rather be associated with IR than triglyceride accumulation and may promote the progression of liver disease via subsequent deteriorations in glucose metabolism.